Consumer Backlash to 'AI Slop' Erodes Trust
A backlash against low-effort, high-volume AI-generated content, dubbed "AI slop," is contributing to a historic collapse in digital and institutional trust. With 78% of consumers reporting all-time low trust in the internet, businesses are being advised to use AI to empower human creativity and service rather than replace it to maintain authenticity.
- The term "AI slop," named Merriam-Webster's word of the year for 2025, refers to low-quality, often mass-produced digital content created by generative AI to attract views and advertising revenue. This content is frequently characterized by a lack of original insight and can include everything from articles with factual errors to nonsensical videos and fake product reviews. - In healthcare, the spread of AI-generated misinformation is a key concern, with 76% of consumers worried it could infiltrate product descriptions, reviews, and chatbots, eroding patient trust. This skepticism creates a significant challenge for providers, as a brand's growth can be constrained by pervasive consumer distrust. - A critical distinction exists between "AI slop" and clinically-focused AI tools used in medical imaging. As of late 2025, the FDA had granted marketing authorization to over 1,000 AI-enabled devices for radiology, which represents about 77% of all such medical device authorizations. - Despite the high number of approvals, a study of 723 radiology AI devices found that less than 30% had undergone clinical testing, and even fewer involved prospective testing or a human operator in the validation process. This gap highlights the need for buyers to scrutinize the clinical evidence supporting AI tools. - For radiology administrators, validated AI is seen as a crucial tool to combat burnout, which is driven by rising imaging volumes and staffing shortages. AI applications can automate routine tasks, triage urgent cases, and improve workflow efficiency, allowing radiologists to focus on complex diagnoses. - The shift of imaging services to outpatient settings is a dominant industry trend, with about 40% of all radiology volume now performed in non-hospital centers. This move is driven by lower costs and site-neutral payment policies, increasing competition among freestanding and mobile imaging providers. - Health systems are responding to these shifts by developing enterprise-wide AI strategies rather than adopting piecemeal solutions. An enterprise approach ensures that AI tools are scalable across specialties like radiology and cardiology, integrate into existing workflows, and provide consistent value. - Executive-level AI strategy in healthcare now requires a robust governance framework to manage risks related to patient safety, data privacy, and model accuracy. This includes "red-teaming" AI models to find vulnerabilities and ensuring that any implemented technology is aligned with core goals like improving patient outcomes or reducing clinical workload.
